Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia

Leukemia and Lymphoma

Volumn 32, Issue 3-4, 1999, Pages 351-358

  Matsumura, Itaru ^a   Horikawa, Yoko ^a   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

c mpl; Essential thrombocythemia; Thrombopoietin

Indexed keywords

ANTIBODY; CYTOKINE RECEPTOR; MESSENGER RNA; PHOSPHOTYROSINE; THROMBOPOIETIN;

ARTICLE; BLOOD LEVEL; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

EID: 0032981805     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909167396     Document Type: Article

References (57)

1. Wehmeier, A., Scharf, R.E., Fricke, S., and Schneider, W. (1989) Bleeding and thrombosis in chronic myeloprolifera tive didorders: Relations of platelet disorders to clinical aspects of the disease. Haemostasis, 19, 251-259.
2. Schafer, AL. (1984) Bleeding and thrombosis in the myelo-proliferative disorders. Blood, 64, 1-12.
3. Fenaux, P., Simon, M., Caulier, M.T., Lai, J.L., Goudemand, J., and Bauters, F. (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer, 66, 549-556.
4. Chistolini, A., Mazzucconi, M.G., Ferrari, A., La Verde, G., Ferrzza, G., Gragoni, F., Vitale, F., Arcieri, R., and Mandelli, F. (1990) Essential thrombocythemia: A retrospective study on the clinical course of 100 patients. Haematologica, 75, 537-540.
5. Fialkow, P.J., Faguet, G.B., Jacobson, R.J., Vaidya, K., and Murphy, S. (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood, 58, 916-919.
6. El-Kasser, N., Hetet, G., Briere, J., and Grandchamp, B. (1997) Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets. Blood, 89, 123-134.
7. Mazur, E.M., Cohen, J.L., and Bogart, L. (1988) Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia. Blood, 71, 1544-1550.
8. Zauli, G., Catani, L., Gugliotta, L., Gaggioli, L., Vitale, L., Mattioli, M., Aglietta, M., and Bagnara, G.P. (1991) Essential thrombocythemia: impaired regulation of megakaryocyte progenitors. Int J Cell Cloning, 9, 43-56.
9. Battegay, E.J., Thomssen, C., Nissen, C., Gudat, F., and Speck, B. (1989) Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol, 42, 321-326.
10. Grossi, A., Vannucchi, A.M., Rafanelli, D., Vannucchi, L., and Ferrini, P. R. (1987) Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases. Am J Hematol, 25, 371-376.
11. Komatsu, N., Suda, T., Sakata, Y., Eguchi, M., Kaji, K., Saito, M., and Miura, Y. (1986) Megakaryocytopoiesis in vitro of patients with thrombocythemia: effect of plasma and serum on megakaryocytic colony formation. Br J Hamatol, 64, 241-252.
12. Han, Z.C., Briere, J., Abgrall, J.F., Sensebe, L., Parent, D., and Guern, G. (1987) Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system. Exp Hamatol, 17, 46-52.
13. Hehlmann, R., John, M., Baumann, B., and Kopcke, W. (1988) Essential thrombocythemia. Cancer, 61, 2487-2496.
14. Bellucci, S., Janvier, M., Tobelem, G., Flandrin, G., Charpak, Y., Berger, R., and Boiron, M. (1986) Essential thrombocythemias. Cancer, 58, 2440-2447.
15. Cortellazzo, S., Barbui, T., Bassan, R., and Dini, E. (1980) Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Thromb Haemost, 43, 127-130.
16. Preston, F.E., Mwth, J.F., Stewart, R.W., and Davies-Jones, G.A.B. (1979) Thrombocytosis, circulating platelets aggregates and neurological dysfunction. Br Med J, 2, 1561-1563.
17. Bazzan, M., Tamponi, G., Schinco, P., Marranca, D., Pileri, A., Bertello, F., Pennone, M., Bassignana, A., and Casaccia, M. (1989) Platelet behavior in essential thrombocythemia: A study of 31 cases. Eur J Haematol, 43, 350-351.
18. Wehmeier, A., Fricke, S., Scharf, R.E., and Schneider, W. (1990) A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders. Eur J Haematol, 45, 191-197.
19. Kaushansky, K. (1995) Thrombopoietin: the primary regulator of platelet production. Blood, 86, 419-431.
20. Kaushansky, K., Lok, S., Holly, R.D., Broudy, V.C., Lin, N., Bailey, M.C., Forstrom, J.W., Buddle, M.M., Oort, P.J., Hagen, F.S., Roth, G.J. Papayannopoulou, T., and Foster, D.C. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature, 369, 568-571.
21. Farese, A.M., Hunt, P., Boone, T., and MacVittie, T.J. (1995) Recombinant human megakaryocyte growth and development factor stimulates thrombopoiesis in normal nonhuman primates. Blood, 85, 54-59.
22. Zeigler, F.C., Sauvage, F., Widmer, H.R., Keller, G.A., Donahue, C., Schreiber, R.D., Malloy, B., Hass, P., Eaton, D., and Matthws, W. (1994) In vitro megakaryopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood, 84, 4045-4052.
23. Gurney, A.L., Carver-Moore, K., Sauvage, F.J., and Moore, M.W. (1994) Thrombocytopenia in c-mpl-deficient mice. Science, 265, 1445-1447.
24. Alexander, W.S., Robert, A.W., Nicola, N.A., Li, R., and Metcalf, D. (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages abd defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood, 87, 2162-2170.
25. de Sauvage, F.J., Carver-Moor, K., Luoh, S.M., Ryan, A., Dowd, M., Eaton, D.L., and Moore, M.W. (1996) Physiological regulation of early and late stages of megakaryopoiesis by thrombopoietin. J Exp Med, 183, 651-656.
26. Miyakawa, Y., Oda, A., Drucker, B.J., Kato, T., Miyazaki, H., Handa, M., and Ikeda, Y. (1995) Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood, 86, 23-27.
27. Miyakawa, Y., Oda, A., Druker, B.J., Miyazaki, H., Handa, M., Ohashi, H., and Ikeda, Y. (1996) Thrombopoietin induces tyrosine phosphorylation of STAT3 and STAT5 in human blood platelets. Blood, 87, 439-446.
28. Ezumi, Y., Takayama, H., and Okuma, M. (1995) Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, Jak2, and STAT3, and enhances agonist-induced aggregation in platelets in vitro. FEBS Letters, 374, 48-52.
29. Kojima, H., Hamazaki, Y., Nagata, Y., Todokoro, K., and Nagasawa, T. (1995) Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost, 74, 1541-1545.
30. Chen, J., Herceg-Harjacek, Groopman, J.E., and Grabarek, J. (1995) Regulation of platelet activation in vitro by the c-Mpl ligand thrombopoietin. Blood, 86, 4054-4062.
31. Kuter, D.J., and Rosenverg, R.D. (1994) Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood, 84, 1464-1472.
32. Stoffel, R., Wiestner, A., and Skoda, R.C. (1996) Thrombopoietin in the thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood, 87, 567-573.
33. Fielder, P.J., Gurney, A.L., Stefanich, E., Marian, M., Moore, M.W., Carver-Moore, K., and de Sauvage, F.J. (1996) Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood, 87, 2154-2161.
34. Fielder P.J., Hass, P., Nagel, M., Stefanich, E., Widmer, R., Bennett, G.L., Keller, G.-A., de Sauvage, F.J., and Eaton, D. (1997) Human platelets as a model for the binding and degradation of thrombopoietin. Blood, 89, 2782-2788.
35. Stefanich, E., Senn, T., Widmer, R., Frantino, C., Keller, G.-A. and Fielder, P. J. (1997) Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood, 89, 4063-4070.
36. Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y., and Kanakura, Y. (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood, 90, 4031-4038.
37. Kosugi, S., Kurata, Y., Tomiyama, Y., Tahara, T., Kato, T., Tadokoro, S., Shiraga, M., Honda, S., Kanakura, Y, and Matsuzawa, Y. (1996) Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Brit J Haematol, 93,704-706.
38. Ichikawa, N., Ishida, F., Shimodaira, S., Tahara, T., Kato, T., and Kitano, K. (1996) Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Thromb Haemost, 76, 156-160.
39. Tahara, T., Usuki, K., Sato, H., Ohashi, H., Morita, H., Tsumura, H., Matsumoto, A., Miyazaki, H., Urabe, A., and Kato, T: (1996) A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haematopoietic disorders. Brit J Haematol, 93, 783-788.
40. Emmons, R.V.B., Reid, D.M., Cohen, R.L., Meng, G., Young, G.M., Dunber, C.E., and Shulman, N.R. (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood, 87, 4068-4071.
41. Cerutti, A., Custodi, P., Duranti, M., Noris, P., and Balduini C. (1997) Thrombopoietin levels in patients with primary and reactive thrombocytosis. Brit J Haematol, 99, 281-284.
42. Moliterno, A.R., Hankins, D., and Spivak, J.L. (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New Eng J Med, 338, 572-580.
43. Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Ishikawa, J., Horikawa, Y., Hashimoto, K., Moriyama, Y., Tsujimura, T., Nishiura, T., Miyazaki, H., and Matsuzawa, Y. (1995) Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood, 86, 703-708.
44. Vigon, I., Mornon, J.P., Cocault, L., Mitjavila, M.T., Tambourin, P., Gisselbrecht, S., and Souyri, M. (1992) Molecular cloning and characterization of MPL, the human homolog of v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89, 5640-5644.
45. Deveaux, S., Filipe, A., Lemarchandel, V, Ghysdael, J., Romeo, P-H., and Mignotte, V. (1996) Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulalion of megakaryocyte-specific genes. Blood, 87, 4678-4685.
46. Lemarchandel, V., Ghysdael, J., Mignotte, V, Rahuel, C., and Romeo, P.-H., (1993) GATA and Ets cis-acting sequences mediate megakaryocyte specific expression. Mol Cell Biol, 13, 668-676.
47. Kaywin, P., Mcdonough, M., Insel, P., and Shattil, S.J. (1978) Platelet function in essential thrombocythemia: Decreased epinephrine responsiveness associated with a deficiency of platelet α-adrenergic receptors. New Eng J Med, 299, 505-509.
48. Schafer, A.I. (1982) Defiencies of platelet lipoxygenase activity in myeloproliferative disorders. New Eng J Med, 306, 381-386.
49. Cooper, B., Schafer, A.I., Puchalsky, D., and Handin, R.I. (1978) Platelet resistance to prostagrandin D2 in patients with myeloproliferative disorders. Blood, 52, 618-626.
50. Moore, A. and Nachman, R.L. (1981) Platelet Fc receptor: Increased expression in myeloproliferative disease. J Clin Invest, 67, 1064-1071.
51. Lowenberg, B. and Touw, P. (1993) Hematopoietic growth factors and their receptors in acute leukemia Blood, 81, 281-292.
52. Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y., Matsuzawa, Y., Kitamura, Y., Kanakura, Y. (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest, 92, 1736-1744.
53. Li, Y., Hetet, G., Kiladjian, J.-J., Gardin, C., Grandchamp, B., and Briere, J. (1996) Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Brit J Haematol, 92, 60-66.
54. Kiladjian, J.J., Elkasser, N., Hetet, G., Briere, J., Grandchamp, B., and Gardin, C. (1997) Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia, 11, 1821-1826.
55. Williams, E.C., and Shahidi, N.T. (1991) Benign familial thrombocytosis. Am J Hematol, 37, 124-125.
56. Schlemper, R.J., van der Maas, A.P.C., and Eikenboom, J.C.J. (1994) Familial essential thrombocythemia : clinical characteristics of 11 cases in one family. Ann Hematol, 68, 153-158.
57. Wiestner, A., Schlemper, R.J., van der Maas, A.P.C., and Skoda, R.C. (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nature Genetics, 18, 49-52.